Universal Health Services, Inc. reported a 6.8% increase in net revenues, reaching $3.548 billion in Q2 2023. Net income attributable to UHS was $171.3 million, or $2.42 per diluted share, compared to $164.1 million, or $2.20 per diluted share, in Q2 2022. Adjusted net income was $179.4 million, or $2.53 per diluted share.
Net revenues increased by 6.8% to $3.548 billion.
Net income attributable to UHS was $171.3 million, or $2.42 per diluted share.
Adjusted net income attributable to UHS was $179.4 million, or $2.53 per diluted share.
The company is increasing the lower end of its guidance range for consolidated net revenues, Adjusted EBITDA, and adjusted EPS for the year ended December 31, 2023.
UHS revised its 2023 operating results forecasts, increasing the lower end of the guidance range for consolidated net revenues, Adjusted EBITDA net of NCI, and adjusted net income attributable to UHS per diluted share. The higher end of the 2023 guidance range for these metrics remains substantially unchanged.
Visualization of income flow from segment revenue to net income